scholarly article | Q13442814 |
P50 | author | Mohamed H Abdel-Rahman | Q59551053 |
Timothy W Grosel | Q86026113 | ||
P2093 | author name string | Joseph P McElroy | |
Colleen M Cebulla | |||
Robert Pilarski | |||
Arun Singh | |||
Meghan J Marino | |||
Frederick H Davidorf | |||
Getachew Boru | |||
James B Massengill | |||
Joanne Jeter | |||
Meredith Stautberg | |||
P2860 | cites work | Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide | Q90281138 |
High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma | Q24170431 | ||
Germline mutations in BAP1 predispose to melanocytic tumors | Q24594891 | ||
Frequent mutation of BAP1 in metastasizing uveal melanomas | Q24601069 | ||
Germline BAP1 mutations predispose to malignant mesothelioma | Q24635326 | ||
RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database | Q24813953 | ||
Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases | Q28397229 | ||
Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. | Q33697377 | ||
Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers | Q34218657 | ||
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families | Q34251101 | ||
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
Role of PTEN, a lipid phosphatase upstream effector of protein kinase B, in epithelial thyroid carcinogenesis | Q34741236 | ||
Germline BAP1 mutations predispose to renal cell carcinomas | Q36909238 | ||
The contribution of germline rearrangements to the spectrum of BRCA2 mutations | Q36930173 | ||
Germline BAP1 alterations in familial uveal melanoma. | Q38805682 | ||
BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma | Q39997349 | ||
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma | Q40082486 | ||
Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations | Q40939840 | ||
High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma | Q43509621 | ||
Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer | Q44246583 | ||
Frequent genomic rearrangements of BRCA1 associated protein-1 (BAP1) gene in Japanese malignant mesothelioma-characterization of deletions at exon level. | Q50948649 | ||
Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. | Q51783814 | ||
Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition. | Q54603640 | ||
The Contribution of Whole Gene Deletions and Large Rearrangements to the Mutation Spectrum in Inherited Tumor Predisposing Syndromes | Q57266419 | ||
Silencing of thePTENtumor-suppressor gene in anaplastic thyroid cancer | Q57591241 | ||
G-quadruplexes in the BAP1 promoter positively regulate its expression | Q57753496 | ||
MSH2 genomic deletions are a frequent cause of HNPCC | Q62977773 | ||
Hereditary uveal melanoma: a report of a germline mutation in BAP1 | Q85938099 | ||
P433 | issue | 9 | |
P921 | main subject | uveal melanoma | Q356372 |
P304 | page(s) | 650-656 | |
P577 | publication date | 2019-04-23 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer | |
P478 | volume | 58 |
Q89817215 | Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma | cites work | P2860 |
Search more.